New and Emerging Immunotherapies for the Treatment of Hematologic Malignancies

February 28, 2023

- This dinner program will be a virtual (online) event. -

Overview:

Immunotherapy has revolutionized cancer treatment over the last decade, and bispecific antibodies are a
rapidly emerging class of immunotherapies in the hematological malignancy space. Bispecific T-cell engagers (BiTE) target CD3 and tumor-specific antigens simultaneously and can further advance the cytotoxicity of T-cells. This program will review the unique mechanism of action of immunotherapies with a focus on BiTEtherapies in hematologic malignancies, including multiple myeloma, lymphoma, and acute lymphoblastic leukemia. Additionally, the faculty will discuss some common adverse effects and management strategies of bispecific antibodies, including cytokine release syndrome.

Learning Objectives:

  • Discuss the mechanism of action of immunotherapies including BiTE therapies
  • Review current and emerging BiTE Therapies for hematologic malignancies
  • Outline common side effects associated with BiTE Therapies including cytokine release syndrome

Target Audience

This activity is intended for oncology pharmacists, pharmacy techs, NPs, PAs, nurses and other healthcare providers involved in the care of cancer patients.

Presented By

                                                   

Course summary
Available credit: 
  • 1.00 ACPE Pharmacy
    The Washington State Pharmacy Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This conference is approved for up to 1.00 credit by the Washington State Pharmacy Association.

    This activity is approved for up to 1.00 credit by the Washington State Pharmacy Association. ACPE#: 0130-9999-21--L01-P | Activity Type: Live| Start/End date: Tue, 02/28/2023 - 2:55pm-Tue, 02/28/2023 - 4:30pm The Washington State Pharmacy Association (WSPA) is accredited by the Accreditation Council for Pharmacy Education as a Provider of continuing pharmacy education. NOTE FOR PHARMACISTS: It is the responsibility of the pharmacist or pharmacy technician to provide the correct information [NABP eProfile ID and DOB (in MMDD format)] within the evaluation, in order to receive credit for participating in this CPE activity. Following the activity’s end date, there is a maximum of 60 days allowed to upload the CPE information to the CPE Monitor. WSPA will upload the CPE information to the CPE monitor 50 days after the activity - please check your CPE Monitor at this time to ensure the CPE is uploaded in your profile. If you encounter any CPE problems, please contact WSPA at 425- 228-7171
  • 1.00 AMA PRA Category 1 Credit™
    Horizon CME designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 ANCC
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. This course is approved by the Nurse Practitioner Healthcare Foundation, California Board of Registered Nursing, CEP# 16441. Upon completion, NPs and RNs will be awarded up to 1.00 credit.
  • 1.00 Pharmacology
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. This course is approved by the Nurse Practitioner Healthcare Foundation, California Board of Registered Nursing, CEP# 16441. Upon completion, NPs and RNs will be awarded up to 1.00 credit.
Course opens: 
01/03/2023
Course expires: 
03/28/2023
Event starts: 
02/28/2023 - 2:55pm PST
Event ends: 
02/28/2023 - 4:30pm PST
Cost:
$0.00
Add to calendar: 
Rating: 
0

Agenda

All Times Listed are for the Eastern Standard Time Zone

Tuesday, February 28, 2023

5:55pmWelcome and Introduction
»  Chung-Shien Lee, PharmD, BCPS, BCOP - St. John's University
6:00pmMeet-the-Clinicians Exhibits (non-CME) 
6:30pmNew and Emerging Immunotherapies for the Treatment of Hematologic Malignancies
»  Syeda Saba Kareem, PharmD, BCOP - Moffitt Cancer Center
7:30pmClosing Comments
»  Chung-Shien Lee, PharmD, BCPS, BCOP - St. John's University
7:35pmExhibits (non-CME)
Online Live Stream
United States

Planning Committee

Chung-Shien Lee, PharmD, BCPS, BCOP (Moderator)

Dr. Chung-Shien Lee is an associate professor in the Department of Clinical Health Professions at St. John’s University. He received his PharmD from St. John’s University College of Pharmacy and Health Sciences. He completed an ASHP-accredited PGY-1 pharmacy residency at North Shore University Hospital and an ASHP-accredited PGY-2 residency in oncology at The Mount Sinai Hospital. Dr. Lee currently provides clinical pharmacy services at Zuckerberg Cancer Center. He is also an active member of the Long Island Society of Health-System Pharmacists and past president. He is currently serving as chair of the Education and Development Committee for the New York State Council of Health-System Pharmacists.

 

Stephen Eng, PharmD, BCOP

Dr. Stephen Eng is a board-certified clinical oncology pharmacy specialist at Memorial Sloan Kettering Cancer Center. He received his PharmD degree from St. John’s University College of Pharmacy and Health Sciences and subsequently went on to complete a PGY1 Pharmacy Practice Residency at Hackensack University Medical Center. He then completed a PGY2 Adult Oncology Residency at Memorial Sloan Kettering Cancer Center (MSKCC). Dr. Eng currently practices in both the inpatient and outpatient setting as a bone marrow transplant clinical pharmacy specialist at MSKCC. He is an active member of the New York City Society of Health-system Pharmacists and serves as the current President for the chapter.

Faculty

Syeda Saba Kareem, PharmD, BCOP

Dr. Kareem graduated from Florida A&M University College of Pharmacy and Pharmaceutical Sciences with a PharmD degree Summa Cum Laude in 2008. She completed a specialty Pharmacy Residency in 2009 at Moffitt Cancer Center in Tampa FL, and became board certified in Oncology Pharmacy in 2014. She is currently pursuing a graduate certification in Precision Medicine with the University of Florida. She has over 10 years of experience in the field of adult hematology oncology, and is an adjunct professor for the University of Florida, and University of South Florida College of Pharmacy precepting pharmacy students and residents over the years. She is currently a clinical pharmacy specialist at Moffitt Cancer Center specializing in the areas of Malignant Hematology, Bone Marrow Transplant, and Cellular Immunology.

Available Credit

  • 1.00 ACPE Pharmacy
    The Washington State Pharmacy Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This conference is approved for up to 1.00 credit by the Washington State Pharmacy Association.

    This activity is approved for up to 1.00 credit by the Washington State Pharmacy Association. ACPE#: 0130-9999-21--L01-P | Activity Type: Live| Start/End date: Tue, 02/28/2023 - 2:55pm-Tue, 02/28/2023 - 4:30pm The Washington State Pharmacy Association (WSPA) is accredited by the Accreditation Council for Pharmacy Education as a Provider of continuing pharmacy education. NOTE FOR PHARMACISTS: It is the responsibility of the pharmacist or pharmacy technician to provide the correct information [NABP eProfile ID and DOB (in MMDD format)] within the evaluation, in order to receive credit for participating in this CPE activity. Following the activity’s end date, there is a maximum of 60 days allowed to upload the CPE information to the CPE Monitor. WSPA will upload the CPE information to the CPE monitor 50 days after the activity - please check your CPE Monitor at this time to ensure the CPE is uploaded in your profile. If you encounter any CPE problems, please contact WSPA at 425- 228-7171
  • 1.00 AMA PRA Category 1 Credit™
    Horizon CME designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 ANCC
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. This course is approved by the Nurse Practitioner Healthcare Foundation, California Board of Registered Nursing, CEP# 16441. Upon completion, NPs and RNs will be awarded up to 1.00 credit.
  • 1.00 Pharmacology
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. This course is approved by the Nurse Practitioner Healthcare Foundation, California Board of Registered Nursing, CEP# 16441. Upon completion, NPs and RNs will be awarded up to 1.00 credit.

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

Access to the internet is required.

Supported Browsers:

Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above

Google Chrome 28.0+ for Windows, Mac OS, or Linux

Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux

Safari 6.0+ for Mac OSX 10.7 and above


Supported Phones & Tablets:

Android 4.0.3 and above

iPhone/iPad with iOS 6.1 or above

How to obtain credit for attendance (eligibility requirement and process for obtaining certificate)
To receive documentation of credit, participants must:

  1. Login to the educational portal

  2. Attend the educational activity

  3. Complete the online evaluation form. The last day to access the evaluation is March 28, 2023 at 11:59pm PST* 

  4. Attest to the number of hours in attendance in order to generate your certificate 

*Requests from learners to claim credit after the evaluation closes will not be granted